Navigation Links
Georgetown University Medical Center licenses 'theranostic' for development
Date:1/24/2012

WASHINGTON, D.C. Georgetown University Medical Center (GUMC) has licensed worldwide rights of a potential novel cancer therapy and diagnostic, or "theranostic," to BioMetrx, LLC. The agent was invented by two Georgetown researchers.

GUMC's license agreement with BioMetrx, LLC, a Maryland-headquartered biotechnology company, expedites the translation of the agent, Rasstore, from the laboratory to the clinical setting for further investigation as a potential new therapy.

Rasstore is named for the novel way it could potentially restore the body's natural ability to suppress tumor cells, utilizing the tumor suppressor gene RASSF1A. The agent was invented by Milton Brown, M.D., Ph.D., director of GUMC's Drug Discovery Program, and Partha Banerjee, Ph.D., a world recognized expert on RASSF1A and tumor suppression, also at GUMC.

"It's rewarding for Partha and me to see an agent progress from concept to where we are today on the verge of completing pre-clinical IND enabling studies for a new agent which we believe has applications in prostate cancer and possibly other cancers as well," said Brown, who holds the Edwin H. Richard and Elisabeth Richard von Matsch Endowed Chair in Experimental Therapeutics and is an associate professor at Georgetown Lombardi Comprehensive Cancer Center.

"Rasstore exemplifies the high-quality, early-stage technologies emerging from Georgetown's robust drug discovery program," says Claudia Stewart, vice president of technology commercialization at Georgetown. "Our commercial relationship with BioMetrx represents the process in universities that harnesses the enthusiasm of seasoned entrepreneurs who form a company around the technology, raise funds and then leverage the technical expertise of the inventors to advance the technology...the start up process."

BioMetrx has begun raising the capital required to support clinical investigation.

"We believe Rasstore will be very attractive to other pharmaceutical companies," says John Wells, BioMetrx's Executive Vice President for Global Operations. "This agent has the potential to enhance existing therapeutics because of its potential to restore the body's natural tumor suppression capability."


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families
2. Georgetown Research Center Helps Reporters Decipher Health Reform Law & Impact on State Residents
3. FDA and Georgetown University Medical Center announce partnership
4. Georgetown research identifies key reasons racial disparities exist in emergent stroke treatment
5. FDA awards Georgetown University a Center of Excellence in Regulatory Science & Innovation
6. Georgetown researchers examine 21-year series of nipple sparing mastectomy cases and find no cancers
7. Georgetown professor applauds decision of researchers to temporarily halt research on H5N1
8. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
9. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
10. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
11. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online ... cosmetictown.com . The forum section was recently revamped and upgraded to allow even more ... in use across the country. , According to the senior editor of Cosmetic Town, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... has been collaborating with doctors and hospitals to make transformative changes in how ... leading cell therapy minds this week in discussing breakthroughs in cellular medicine to ...
(Date:4/28/2016)... Washington D.C. (PRWEB) , ... April 28, 2016 , ... USA Medical Card reminds us ... and Prevention (CDC), a stroke is the fourth leading cause of death in the United ... country, with almost a quarter of them in individuals under 65 years old. A ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... M.D. has been named a Top Doc in Physical Medicine and Rehabilitation by ... with Castle Connolly Medical, Ltd. by randomly surveying physicians and medical leadership across ...
(Date:4/28/2016)... ... 2016 , ... Denise McCormick Baich had written poetry dating back to her childhood, but after ... a tsunami and took on a more spiritual tone. The desire to put the words ... with it than just file it away. Friends would ask her how she wrote such ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
(Date:4/27/2016)... , April 27, 2016 ... over USD 2.14 billion by 2022, according to ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ... advancement affecting the efficiency and accuracy delivered by ... persistent demand for novel urinalysis instruments and consumables. ...
(Date:4/26/2016)... CHICAGO , April 26, 2016 Hill-Rom Holdings, ... to a management presentation at the Deutsche Bank 41 st ... at 2:50 p.m. EDT. You are invited to ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/mr4uxgas ... one hour after conclusion of the live event and accessible ...
Breaking Medicine Technology: